Silco Pharmaceuticals Limited (DSE:SILCOPHL)
Bangladesh
· Delayed Price · Currency is BDT 13.00
+0.40 (3.17%)
At close: Mar 9, 2026
Silco Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 31.9 | 28.7 | 30.76 | 26.72 | 53.03 | 101.97 | Upgrade
|
| Short-Term Investments | - | 1.77 | 18.97 | 37.91 | 19.41 | 155.95 | Upgrade
|
| Cash & Short-Term Investments | 31.9 | 30.47 | 49.73 | 64.63 | 72.44 | 257.92 | Upgrade
|
| Cash Growth | -48.73% | -38.73% | -23.04% | -10.79% | -71.91% | -14.52% | Upgrade
|
| Receivables | 429.81 | 419.59 | 377.51 | 389.24 | 390.53 | 484.99 | Upgrade
|
| Inventory | 448.06 | 444.1 | 444.14 | 457.84 | 449.45 | 454.71 | Upgrade
|
| Prepaid Expenses | - | 0.59 | - | 0.21 | 0.21 | 0.21 | Upgrade
|
| Other Current Assets | 128.28 | 160.19 | 133.55 | 136.83 | 139.59 | 126.93 | Upgrade
|
| Total Current Assets | 1,038 | 1,055 | 1,005 | 1,049 | 1,052 | 1,325 | Upgrade
|
| Property, Plant & Equipment | 1,742 | 1,767 | 1,762 | 1,671 | 1,643 | 1,334 | Upgrade
|
| Other Long-Term Assets | 0 | - | -0 | -0 | 0 | 0 | Upgrade
|
| Total Assets | 2,781 | 2,822 | 2,767 | 2,720 | 2,696 | 2,659 | Upgrade
|
| Accounts Payable | 9.03 | 9.6 | 9.75 | 12.33 | 16.15 | 16.58 | Upgrade
|
| Accrued Expenses | 10.91 | 9.18 | 9.27 | 16.93 | 21.21 | 14.87 | Upgrade
|
| Current Portion of Leases | 3.78 | 4.26 | - | 4.11 | 3.77 | - | Upgrade
|
| Current Income Taxes Payable | 193.51 | 285.19 | 273.7 | 255.21 | 240.41 | 223.62 | Upgrade
|
| Other Current Liabilities | 2.16 | 2.56 | 3.04 | 2.33 | 1.42 | 4.79 | Upgrade
|
| Total Current Liabilities | 219.39 | 310.8 | 295.76 | 290.91 | 282.96 | 259.86 | Upgrade
|
| Long-Term Leases | - | 5.31 | - | - | 4.11 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 154.9 | 153.71 | 151.73 | 150.21 | 140.5 | 152.3 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | -0 | - | 0 | -0 | Upgrade
|
| Total Liabilities | 374.29 | 469.82 | 447.5 | 441.11 | 427.57 | 412.17 | Upgrade
|
| Common Stock | 1,038 | 1,038 | 1,038 | 1,038 | 1,038 | 1,038 | Upgrade
|
| Retained Earnings | 1,368 | 1,316 | 1,289 | 1,251 | 1,230 | 1,208 | Upgrade
|
| Comprehensive Income & Other | - | -1.15 | -6.92 | -10.69 | -0.37 | - | Upgrade
|
| Shareholders' Equity | 2,406 | 2,352 | 2,320 | 2,279 | 2,268 | 2,246 | Upgrade
|
| Total Liabilities & Equity | 2,781 | 2,822 | 2,767 | 2,720 | 2,696 | 2,659 | Upgrade
|
| Total Debt | 3.78 | 9.57 | - | 4.11 | 7.89 | - | Upgrade
|
| Net Cash (Debt) | 28.12 | 20.9 | 49.73 | 60.51 | 64.56 | 257.92 | Upgrade
|
| Net Cash Growth | -45.47% | -57.97% | -17.82% | -6.26% | -74.97% | -14.52% | Upgrade
|
| Net Cash Per Share | 0.28 | 0.20 | 0.48 | 0.58 | 0.62 | 2.48 | Upgrade
|
| Filing Date Shares Outstanding | 102.08 | 103.81 | 103.81 | 103.81 | 103.81 | 103.81 | Upgrade
|
| Total Common Shares Outstanding | 102.08 | 103.81 | 103.81 | 103.81 | 103.81 | 103.81 | Upgrade
|
| Working Capital | 818.66 | 744.14 | 709.17 | 757.83 | 769.27 | 1,065 | Upgrade
|
| Book Value Per Share | 23.57 | 22.66 | 22.35 | 21.95 | 21.85 | 21.64 | Upgrade
|
| Tangible Book Value | 2,406 | 2,352 | 2,320 | 2,279 | 2,268 | 2,246 | Upgrade
|
| Tangible Book Value Per Share | 23.57 | 22.66 | 22.35 | 21.95 | 21.85 | 21.64 | Upgrade
|
| Land | - | 74.85 | 74.85 | 74.85 | 74.85 | 74.85 | Upgrade
|
| Buildings | - | 1,083 | 1,004 | 880.25 | 700.05 | 477.1 | Upgrade
|
| Machinery | - | 1,576 | 1,524 | 1,443 | 1,320 | 1,317 | Upgrade
|
| Construction In Progress | - | 128.1 | 174.96 | 197.38 | 394.59 | 243.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.